NDC codes

FDA NDC Directory
Product NDC (as listed)27241-133Labeler and product segments. Claims need a package NDC.
Product NDC at billing width27241-0133Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
27241-133-0427241013304100 TABLET in 1 BOTTLE (27241-133-04)Marketed from Sep 11, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Acetazolamide
Generic name (nonproprietary)
acetazolamide
Active ingredients
Acetazolamide — 250 mg/1
Dosage form
Tablet
Route
Oral
Labeler
Ajanta Pharma USA Inc.NDC labeler code 27241
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 211151
Marketing start
Listing expires
Other FDA classes
Carbonic Anhydrase Inhibitors (Mechanism)Sulfonamides (Chemical structure)
Identifiers
Product ID 27241-133_65c27c82-082a-4995-b44d-641817b4c587SPL ID 65c27c82-082a-4995-b44d-641817b4c587SPL set ID 240ab24b-3124-4805-80c2-36dd1945e3b3RxCUI 197303, 197304UNII O3FX965V0IUPC 0327241133046, 0327241132049
Pharmacologic class
Carbonic Anhydrase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N427241013304 followed by a unit qualifier and the quantity

Package 27241-0133-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INDICATIONS AND USAGE For adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies (petit mal, unlocalized seizures); chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure. Acetazolamide tablets, USP are also indicated for the prevention or amelioration of symptoms associated with acute mountain sickness in climbers attempting rapid ascent and in those who are very susceptible to acute mountain sickness despite gradual ascent.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 27241-133

What is NDC 27241-133?
27241-133 is the product NDC for Acetazolamide, Acetazolamide 250 mg/1 tablet, listed with the FDA by Ajanta Pharma USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Acetazolamide.
What is the active ingredient?
Acetazolamide.
Who is the labeler?
Ajanta Pharma USA Inc., NDC labeler code 27241. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Acetazolamide?
70 other product NDCs are listed under this name. See all Acetazolamide NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Acetazolamide NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
AcetazolamideAcetazolamide 500 mg/1Capsule, Extended releaseOralREMEDYREPACK INC.70518-464670518-4646-00
AcetazolamideAcetazolamide 125 mg/1TabletOralMarlex Pharmaceuticals, Inc.10135-83010135-0830-01
AcetazolamideAcetazolamide 250 mg/1TabletOralMarlex Pharmaceuticals, Inc.10135-83110135-0831-01
Acetazolamideacetazolamide sodiumAcetazolamide sodium 500 mg/5mLInjection, Powder, For solutionIntravenousSagent Pharmaceuticals25021-83925021-0839-20
AcetazolamideAcetazolamide sodium 500 mg/5mLInjection, Powder, Lyophilized, For solutionIntravenousGland Pharma Limited68083-66168083-0661-01
AcetazolamideAcetazolamide 125 mg/1TabletOralAurobindo Pharma Limited59651-90559651-0905-01
AcetazolamideAcetazolamide 250 mg/1TabletOralAurobindo Pharma Limited59651-90659651-0906-01
AcetazolamideAcetazolamide 125 mg/1TabletOralAarkish Pharmaceuticals NJ Inc.81005-10481005-0104-0181005-0104-10
AcetazolamideAcetazolamide 250 mg/1TabletOralAarkish Pharmaceuticals NJ Inc.81005-10581005-0105-0181005-0105-10
AcetazolamideAcetazolamide 125 mg/1TabletOralAjanta Pharma USA Inc.27241-13227241-0132-04

All 71 Acetazolamide NDCs

Other NDCs under ANDA 211151

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211151
ProductStrengthForm · routeLabelerProduct NDC
AcetazolamideAcetazolamide 125 mg/1TabletOralAjanta Pharma USA Inc.27241-132

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in
Acetazolamide NDC 27241-133 | National Drug Code | Med-Code